InnovaRx Innova Health Strategies

H16.051

Mooren's corneal ulcer, right eye

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 11 never code together
H00-H59chapter
Excludes2
  • certain conditions originating in the perinatal period (P04-P96)P04-P96
  • certain infectious and parasitic diseases (A00-B99)A00-B99
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
  • congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)Q00-Q99
  • diabetes mellitus related eye conditions (E09.3-, E10.3-, E11.3-, E13.3-)E09.3-E10.3-E11.3-E13.3-
  • endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
  • injury (trauma) of eye and orbit (S05.-)S05.-
  • injury, poisoning and certain other consequences of external causes (S00-T88)S00-T88
  • neoplasms (C00-D49)C00-D49
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94
  • syphilis related eye disorders (A50.01, A50.3-, A51.43, A52.71)A50.01A50.3-A51.43A52.71

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 1
H00-H59chapter
Notes
  • Use an external cause code following the code for the eye condition, if applicable, to identify the cause of the eye condition
Index entries leading here 1
  • Ulcer, ulcerated, ulcerating, ulceration, ulcerative
Alongside this code 3 same parent — H16.05
Medications 1

MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.

Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
H16.05
Block
H15-H22
Siblings
3

Present FY2024–FY2027.